IAnthus Capital Cash And Equivalents vs. Market Capitalization

ITHUF Stock  USD 0.01  0  12.50%   
Taking into consideration IAnthus Capital's profitability measurements, iAnthus Capital Holdings may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in April. Profitability indicators assess IAnthus Capital's ability to earn profits and add value for shareholders.
For IAnthus Capital profitability analysis, we use financial ratios and fundamental drivers that measure the ability of IAnthus Capital to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well iAnthus Capital Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between IAnthus Capital's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of iAnthus Capital Holdings over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between IAnthus Capital's value and its price as these two are different measures arrived at by different means. Investors typically determine if IAnthus Capital is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IAnthus Capital's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

iAnthus Capital Holdings Market Capitalization vs. Cash And Equivalents Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining IAnthus Capital's current stock value. Our valuation model uses many indicators to compare IAnthus Capital value to that of its competitors to determine the firm's financial worth.
iAnthus Capital Holdings is rated below average in cash and equivalents category among its peers. It also is rated below average in market capitalization category among its peers creating about  5.13  of Market Capitalization per Cash And Equivalents. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IAnthus Capital's earnings, one of the primary drivers of an investment's value.

IAnthus Market Capitalization vs. Cash And Equivalents

Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

IAnthus Capital

Cash

 = 

Bank Deposits

+

Liquidities

 = 
29.8 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

IAnthus Capital

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
152.75 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

IAnthus Market Capitalization vs Competition

iAnthus Capital Holdings is rated below average in market capitalization category among its peers. Market capitalization of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 4.33 Billion. IAnthus Capital holds roughly 152.75 Million in market capitalization claiming about 4% of equities under Drug Manufacturers—Specialty & Generic industry.
Capitalization  Workforce  Valuation  Total debt  Revenue

IAnthus Capital Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in IAnthus Capital, profitability is also one of the essential criteria for including it into their portfolios because, without profit, IAnthus Capital will eventually generate negative long term returns. The profitability progress is the general direction of IAnthus Capital's change in net profit over the period of time. It can combine multiple indicators of IAnthus Capital, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. The company was founded in 2014 and is headquartered in New York, New York. Ianthus Capital operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.

IAnthus Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on IAnthus Capital. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of IAnthus Capital position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the IAnthus Capital's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in IAnthus Capital without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

Use Investing Themes to Complement your IAnthus Capital position

In addition to having IAnthus Capital in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Biotech Thematic Idea Now

Biotech
Biotech Theme
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in IAnthus Pink Sheet

To fully project IAnthus Capital's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of iAnthus Capital Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include IAnthus Capital's income statement, its balance sheet, and the statement of cash flows.
Potential IAnthus Capital investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although IAnthus Capital investors may work on each financial statement separately, they are all related. The changes in IAnthus Capital's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on IAnthus Capital's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.